Pharmaceutical Outsourcing

View online

Forward to a friend | Facebook | Twitter

Featured Articles | Featured Partners | Videos | Industry News | Events

November 04, 2025

Newsletter Sponsor

De-risk Biologics with Developability & Formulation Insights
Accelerate smarter biologics development with Catalent’s Developability and Formulation expertise. Our systematic approach combines predictive in silico modeling, forced degradation studies, and formulation screening to identify risks early, optimize candidate selection, and define shelf-life stability. Whether during discovery or cell line development, Catalent’s dedicated BioAnalytics team helps you predict manufacturability, solubility, and stability—streamlining your path from molecule to clinic with data-driven confidence.

	Industry News

	Peli BioThermal Opens Expanded Allentown, PA Service Center to Support Growing Cold Chain Demands Peli BioThermal announced that its newly expanded Allentown, Pennsylvania Service Center is ... read more »

	Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium Ginkgo Bioworks has been awarded a contract through the Biomedical Advanced Research and Development... read more »

	Sharp Services Invests $100M in US and European Facilities to Increase Capacity and Service Offerings Sharp Services announced a $100M investment across its global facility network to address increasing... read more »

	Orion and Abzena Announce Exclusive Commercial License for Abzena’s Antibody Abzena announced that Orion has obtained an exclusive focused commercial license to one of Abzena’s ... read more »

	Featured Articles

		How Tariffs Could Impact Your Drug Development Supply Chain: Top Five Things to Be Aware Of The pharmaceutical industry is entering a period of intensified trade disruption. With new tariffs on imported raw materials, active pharmaceutical ingredients (APIs), and medical components, global ... read more »

		Challenges in Developing Analytical Procedures with the New ICH Q14 Guideline The current effective version of ICH Q14-Analytical Procedure Development was adopted on 1 November 2023. Development of analytical procedures under the new ICH Q14 guideline poses significant ... read more »

	Featured Video

Cell & Gene Therapy: Advancing the Next Generation of Pharmaceuticals
In this documentary, American Pharmaceutical Review and Pharmaceutical Outsourcing magazine spoke with industry experts to learn how cell and gene therapies are changing the healthcare landscape and ... read more »

Watch Video: Pyramid Laboratories Facility Tour
PYRAMID Laboratories, Inc. is a CDMO, focused on parenteral drug products, that offers comprehensive pipeline of services to pharmaceutical and biotech companies. read more »

	More Services

Clinical Trial Services Learn More
ADME DMPK Learn More
Formulation & Preformulation Services Learn More

	Service Directory

Clinical Trial Data Management Outsourcing / Data Management CRO Search More

Clinical Trial Development Services and Outsourcing Search More

	Events

AAPS 2025 PharmSci 360
Henry B. Gonzalez Convention Center – 11/09/2025
AAPS is the convener of the pharmaceutical science community, bringing together thousands of scientists from across the world and the drug development... event details »

Harness the Power of AI in GxP – Dublin Edition
Dublin, Ireland or Attend Virtually – 11/19/2025
Due to overwhelming demand, KENX is bringing its groundbreaking AI in GxP conference to Europe. Discover practical applications of AI in validation, ... event details »

This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription | Unsubscribe | Contact Pharmaceutical Outsourcing

Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA